Market News / Story
TRex Bio, Inc. Prices $116.7M IPO at $14
·
TRex Bio priced 8,333,334 shares at $14 for gross proceeds of approximately $116.7M, with trading expected to begin Oct. 9 on Nasdaq as TRXB. Underwriters have a 30-day option for up to 1,250,000 additional shares. Material Details #DetailAI Analyst View1IPO priced at $14/shareSets initial valuation and anchors first-day trading ranges.28,333,334 shares offeredIndicates initial float size and supply at the open.3Gross proceeds ~$116.7MCash runway impact for clinical…